Rule 8.3 - Biotrace Int.
09 October 2006 - 11:30PM
UK Regulatory
RNS Number:1682K
DKR Ibex Management L.P.
09 October 2006
FORM 8.3
DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE
(Rule 8.3 of the Takeover Code)
1. KEY INFORMATION
Name of person dealing (Note 1)
DKR IBEX MANAGEMENT L.P.
Company dealt in
BIOTRACE INTERNATIONAL PLC
Class of relevant security to which
the dealings being disclosed relate
(Note 2)
ORDINARY SHARES 10P
Date of dealing
06 OCTOBER 2006
2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
(1) Relevant securities 65,000 0.17%
(2) Derivatives (other than options) 645,000 1.64%
(3) Options and agreements to
purchase/sell
Total 710,000 1.81%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to
purchase/sell
Total
(c) Rights to subscribe (Note 3)
Class of relevant security: Details
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of securities Price per unit (Note 5)
PURCHASE 5,000 130.4721
(b) Derivatives transactions (other than options)
Product Long/short Number of Price per
name, e.g. (Note 6) securities unit (Note 5)
CFD (Note 7)
TOTAL RETURN SWAP LONG 30,000 129.8239
CFD LONG 15,000 129.8239
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name,e.g. selling, securities price e.g. date money
call purchasing, to which American, paid/
option varying the option European received
etc. relates etc. per unit
(Note 7) (Note 5)
(ii) Exercising
Product name, Number of Exercise price per unit
e.g. call option securities (Note 5)
(d) Other dealings (including new securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this should be
stated.
NONE
..............................................................................
..............................................................................
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 09 OCTOBER 2006
Contact name ERICA FRY
Telephone number 203 324 8464
If a connected EFM, name of offeree
/offeror with which connected N/A
If a connected EFM, state nature of
connection (Note 10) N/A
Notes
The Notes on Form 8.3 can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
RETFSUFDUSMSEFS
Bank Irel13.375 (LSE:BOI)
Historical Stock Chart
From Dec 2024 to Jan 2025
Bank Irel13.375 (LSE:BOI)
Historical Stock Chart
From Jan 2024 to Jan 2025
Real-Time news about Bank Irel13.375 (London Stock Exchange): 0 recent articles
More Biotrace Int. News Articles
